2 recruiting, 1 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
Follow B-Cell Lymphoproliferative Disorder: new trials by email Literature Review of B-Cell Lymphoproliferative Disorder trials Research Report on B-Cell Lymphoproliferative Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia Pacritinib - Waldenström Macroglobulinemia, Lymphoplasmacytic Lymphoma | Phase 2 | Recruiting | Shayna Sarosiek, MD | 30 | 2025-11-21 | 2025-12-05 |
| Epcoritamab in Previously Treated WM Epcoritamab - Waldenstrom Macroglobulinemia, B-Cell Lymphoproliferative Disorder | Phase 2 | Recruiting | Gottfried von Keudell, MD PhD | 20 | 2024-12-06 | 2026-03-13 |
| Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx IGH Assay IdentiClone Dx IGH (IC IGH Dx) Assay - B-Cell Lymphoproliferative Disorder | Completed | Invivoscribe, Inc. | 250 | 2024-01-02 | 2024-12-04 |
Waldenstrom Macroglobulinemia (2) · Lymphoma (1) · Lymphoma, B-Cell, Marginal Zone (1)
Blood Protein Disorders (2) · Cardiovascular Diseases (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Hemorrhagic Disorders (2) · Hemostatic Disorders (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphatic Diseases (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Plasma Cell (2) · Paraproteinemias (2) · Vascular Diseases (2)
Gottfried von Keudell, MD PhD (1) · Invivoscribe, Inc. (1) · Shayna Sarosiek, MD (1)
United States (3) · Germany (1) · Japan (1)
Gottfried von Keudell, MD (1) · Shayna Sarosiek, MD (1)